latest news releases from the newsroom
Creative Products Company
Metrolosys Inspection Software Under New Management of Creative Products Company
CHINO, Calif., May 8, 2006 (PRIMEZONE) -- Creative Products Company announced today it will manage the sales, marketing, and product development of the Metrolosys inspection software product line. Metrolosys v9.5 (www.metrolosys.com) is the leading inspection software for machine tool probing that transforms any machine tool into a Coordinate Measuring Machine (CMM). Creative Products Company specializes in manufacturing software development, and offers CNC machining and high-end laser engraving services. Creative Products Company is located at 5670 Schaefer Avenue, Suite J, Chino, CA 91710. The company can be reached at (909) 591-3638 or via email: firstname.lastname@example.org.
Nayna Networks, Inc.
Nayna Networks and WICE-NET, Ltd. Announce US$12 Million Network Solutions Agreement
SANTA CLARA, Calif. and MUMBAI, India, May 8, 2006 (PRIMEZONE) -- Nayna Networks, Inc. (OTCBB:NAYN), a provider of next-generation network solutions headquartered in Santa Clara, California, USA, and WICE-NET, Ltd., a provider of broadband access services in the India subcontinent and Africa, today announced they have finalized an agreement through which Nayna will be the exclusive network systems solutions and equipment provider for WICE-NET's triple-play broadband access deployments.
DTLL Engages CRT Capital for $75 Million in Financing
BLOOMINGTON, Minn., May 8, 2006 (PRIMEZONE) -- DTLL, Inc. ("DTLL") (OTCBB:DTLI) announced today that it has engaged CRT Capital Group (www.crtllc.com) to provide up to $75 million dollars in financing for the purchase of Grand Sierra Resorts Corporation, the Reno Hilton and Casino from Harrah's Entertainment and other company projects.
Novo Nordisk A/S
Novo Nordisk: Director/PDMR Shareholding
BAGSVAERD, Denmark, May 8, 2006 (PRIMEZONE) -- In accordance with Section 28a of the Danish Securities Trading Act, Novo Nordisk is required on a daily basis to publish trading in Novo Nordisk shares by the company's board members, executives and their associated persons as reported by those persons to Novo Nordisk.